Objective: We investigated the effects of zidovudine (AZT) on cardiac and vascular smooth muscle function and morphology in rats. Methods: Four adult male Wistar-Kyoto rats received AZT in drinking water for 240 days; four rats served as controls. Echocardiographic examination and systolic blood pressure (SBP) measurement were performed. At the end of treatment the rats were sacrificed, their hearts were weighed and vascular smooth muscle contractile and relaxing properties were evaluated in vitro on endothelium-intact aortic rings. Morphological studies were performed on cardiac and aortic myocytes by light and electron microscopy. Results: AZT-treated rats (AZT-Rs) showed higher SBP, greater heart weight and, as revealed by echocardiography, greater interventricular septum thickness. Electron microscopy revealed mitochondrial swelling in myocardiocytes in AZT-Rs. Reduced response to contractile stimuli and enhanced relaxation in response to charbacol were observed in the aortic rings of AZT-Rs. The aortic myocytes of AZT-Rs contained apparently unaffected ultrastructural features, but light microscopy suggested their marked enlargement. Conclusions: AZT treatment for 240 days in rats induces a modest increase in SBP, hypertrophy of the interventricular septum and modified vascular smooth muscle responsiveness. The role of mitochondria in these AZT-induced cardiovascular alterations remains to be established.
. Introduction
inhibitory effect on DNA polymerase-g, the matrix enzyme involved in mitochondrial DNA synthesis, with consequent Zidovudine (AZT) (39-azido-39-deoxythymidine) is an impairment of mitochondrial protein synthesis and alteraantiretroviral drug largely employed in the treatment of tions of the activity of mitochondrial enzymes, i.e., respirahuman immunodeficiency virus (HIV) infection. AZT tory chain proteins [2, 3] . In vivo and in vitro studies have antiretroviral activity is due to the inhibition of the HIV-1 demonstrated that muscles represent important targets for reverse transcriptase, which determines termination of the AZT-induced toxicity [4] . Alterations of either cardiac or newly synthesized viral DNA chain [1] . Unfortunately, skeletal muscle function have been reported in animals AZT therapy has been shown to cause several unwanted chronically treated with the drug [5] [6] [7] [8] ; these results are in effects ascribed to mitochondrial damage mediated by an agreement with clinical observations in AZT-treated patients, in whom skeletal muscle weakness and, less frequently, cardiomyopathy have been described [4, 9, 10] . In both animals and humans, muscle toxicity has paralleled ultrastructural mitochondrial damage, suggesting a role of intervals, and the mean value of five measurements was mitochondria in the pathogenesis of skeletal and cardiac calculated. alterations [4] [5] [6] [7] .
Available data concerning AZT-induced toxicity on the 2 .3. Echocardiographic evaluation cardiovascular system of animals are limited to the heart and refer to treatments lasting from 14 to 90 days [5] [6] [7] .
To perform echocardiographic studies, rats were anesLonger animal treatments, more closely representing the thetized with an association of ketamine (80 mg / kg) and duration of AZT therapy in AIDS patients, could offer xylazine (20 mg / kg), and their chests were shaved. The more reliable information on the features and the extent of examination was undertaken, with the animals positioned AZT-induced cardiac toxicity. Moreover, since it has been on their backs, using a Hewlett-Packard Sonos 5500 shown that AZT slowly accumulates in smooth muscle [7] , echocardiographer equipped with an S12 (5 to 12 MHz) a longer treatment could allow assessment of possible probe. The following parameters were measured, according AZT-related damage in vascular tissue. Accordingly, this to the recommendations of the American Academy of study was undertaken to investigate in rats the effects of a Echography for Humans [13] : left ventricular end diastolic 240-day AZT treatment protocol on cardiac and vascular and end systolic dimensions; left ventricular posterior wall functions, as evaluated in vivo and in vitro, and on the and interventricular septum thickness; end diastolic and ultrastructural morphology of cardiac and vascular end systolic dimensions (M-mode); ejection fraction and myocytes.
fractional shortening. Each measurement was performed three times, and the reported values are the average of the three measurements indexed for body weight (Table 2 ). AZT in drinking water ad libitum; the other four animals under 1.5 g of resting force and left to equilibrate for 45 were used as controls. AZT was dissolved in drinking min before starting the experiment. The aortic contractile water at a concentration (1 mg / ml) calculated on the basis function was evaluated by measuring the developed tenof the daily water intake of a rat (20-45 ml), so that each sion in response to either the receptor-coupled vasocon-1 rat was treated with approximately 100 mg / kg / day AZT, strictor agent phenylephrine or to the increase in K which closely corresponds to the intake reported in previconcentration to 80 mM in the physiological salt solution. ous studies [6, 11] . Prior to drug administration, every 30
. Methods

.4. Evaluation of contractile function of vascular smooth muscle
Endothelium-dependent relaxation of vascular rings was days during the treatment period and at its conclusion, the evaluated by exposing phenylephrine-contracted vessels to rats were weighed, their systolic blood pressure (SBP) was charbacol. In order to correctly compare the results bemeasured, and echocardiographic evaluation was pertween treated and untreated rats, care was taken to use the formed. At the end of AZT administration, the animals same aortic segment from each animal as previously were sacrificed by cervical dislocation, and the heart and described [15] ; each aorta was cut into 2-mm-long rings the thoracic aorta were excised for the ex vivo evaluations.
under a dissection microscope.
.2.
Measurement of systolic blood pressure 2 .5. Light and electron microscopy studies and morphometry The SBP of conscious, warmed and unrestrained rats was measured by the tail-cuff plethysmographic method Sliced pieces of the left ventricle and the aortic wall (Ugo Basile, Comerio, Italy) as previously described [12] .
were fixed in 3% glutaraldehyde in 0.1 M cacodylate For each rat, five measurements were made at 10-min buffer, postfixed in 1% osmium tetroxide in 0.1 M phosphate buffer, and embedded in an epoxy resin. Thick (0.5 mm) and thin (60-70 nm) sections were cut by an LKB-III ultramicrotome. Thick sections were stained with toluidine blue, and examined by a camera-connected Leitz Laborlux microscope. Thin sections were counterstained with lead hydroxide and examined by an Hitachi H-300 electron microscope. For each rat, three tissue blocks of left ventricle and aortic wall were examined, and two series of thick and thin sections for each block were selected. Three light micrographs were recorded at a magnification of 3003 for each series of thick sections of aortic wall. For each series of thin sections, six electron micrographs at a final magnification of 21,0003 were recorded for stereological analysis. The numerical density ANOVA. Each point represents mean6S.E.M., n54.
cristae (mm /mm of mitochondria) were measured on the electron micrographs using the conventional stereologic 3 .3. Effects of AZT treatment on the heart techniques previously detailed [16] .
AZT treatment did not significantly affect heart rate 2 .6. Statistical analysis (Fig. 3) . Echocardiographic evaluation over the course of the 240 day protocol showed a decrease in the investigated Blood pressure, body weight, heart rate time-courses indexed dimensional parameters in both AZT-Rs and and echocardiographic parameters were compared by two-CNT-Rs, with the exception of the interventricular septum way repeated measure analysis of variance (ANOVA).
thickness which was increased only in AZT-Rs (Fig. 4A Student's t-tests was employed to compare heart weight, C and Table 1 ). Heart weight, normalized to body weight mitochondrial damage and aortic ring results. Significance (BW), was also significantly greater in AZT-Rs compared was set at P,0.05.
to CNT-Rs (3.260.05 vs. 2.6860.07 mg / g / BW, n54, P,0.01) (Fig. 4D ). Ultrastructural analysis of the hearts of 2 .7. Drugs and solutions AZT-Rs revealed mitochondrial enlargement and loss of  matrix electron-density, without disruption of cristae arCommercially available AZT (Retrovir syrup) was chitecture (Fig. 5 ). Stereology showed a 60% increase in diluted in the drinking water to obtain the final AZT mitochondrial volume, coupled with a 35% decrease in the concentration (1 mg / ml). Phenylephrine and charbacol surface density of their cristae. The cristae surface per were purchased from Sigma-Aldrich (St. Louis, MO, 1 USA) and were dissolved in bidistilled water. High K solution used in ring experiments was obtained by adding KCl to the physiological salt solution.
. Results
.1. General
No differences were observed in the time-course of the body weight between control rats (CNT-Rs) and AZT-Rs (Fig. 1) . The observation of AZT-Rs did not reveal any abnormality in behavior, motor activity and appearance. In AZT group, the 240-day value of interventricular septum systolic thickness was significantly greater than the basal value. Values are indexed to the body weight. Data are means6S.E.M., n54. IVSTd5Interventricular septum diastolic thickness; LVDd5left ventricu- Fig. 3 . Time-course of heart rate in CNT-Rs and AZT-Rs. Basal heart lar diastolic dimension; PWTd5posterior wall diastolic thickness; rate values were 336639 beats / min in CNT-Rs and 370638 beats / min IVSTs5interventricular septum systolic thickness; LVDs5left ventricular in AZT-Rs. At the end of the treatment, heart rate was 31268 beats / min systolic dimension; PWTs5posterior wall systolic thickness; FS5 in CNT-Rs and 316624 beats / min in AZT-Rs. Data were analysed by fractional shortening; EF5ejection fraction. * P,0.05 compared to basal two-way repeated measures ANOVA. Each point represents AZT-Rs value. mean6S.E.M., n54. (Fig. 6A) the aortas of AZT-Rs compared to CNT-Rs (Fig. 6B) of aortic rings precontracted by 10 mM phenylephrine was significantly enhanced in AZT-Rs as compared to CNT-Rs mitochondrion was unchanged (Table 2) , thereby indicat-(73 vs. 54%, n512, P,0.01) (Fig. 6C) . ing the occurrence of mitochondrial swelling, which Light microscopy evidenced a net decrease in the accords well with its light matrix.
.2. Effects of AZT treatment on SBP
number of myocytes in the unit area of the aortic wall of AZT-Rs. Morphometry showed a 24% decrease in the 3 .4. Effects of AZT treatment on the aorta numerical density of myocytes (control 21056185 vs. AZT 16086151; P,0.05), thereby suggesting an increase KCl-induced contraction (80 mM) was blunted in AZTin their average volume (Fig. 7) . Conversely, electron evaluation. Indeed, as far as energy supply and hence contractile function are concerned, the increase in the number of mitochondria may compensate the functional alteration likely associated with their swelling. The increased thickness of the interventricular septum in AZT-Rs indicates a hypertrophic response and may be an early manifestation of the generalized hypertrophy which characterizes many metabolic disorders involving alterations of myocardial energy metabolism [17] . This hypertrophic response, paralleled by an increase in heart weight, is in accordance with the previous report that describes the development of cardiac hypertrophy evaluated echocardiographically, accompanied by an increase in heart weight, in mice treated for 21 days with AZT [5] . However, the observed increase in SBP of this study might also be related to the development of cardiac hypertrophy in AZT-Rs. In fact, the AZT-induced increase in SBP represents a completely new finding since it has not been previously described. Our data in vitro also show for the first time that AZT treatment affects vascular smooth muscle function, inducing a marked reduction in the 1 contractile responses to either high K or phenylephrine.
1
The high K -induced contraction is due to membrane 21 depolarization and is completely dependent on Ca entrance through voltage-operated calcium channels [18] . At variance, the agonist-induced contraction is due to the activation of a receptor, and the increase in cytoplasmic 21 Ca concentration triggering the response is consequent 21 21 both to Ca release from intracellular stores and Ca 21 entrance through a variety of Ca channels [18] . The alteration in the ability of vascular myocytes to contract, rather than a defect in a specific receptor mechanism, since microscopy did not reveal any appreciable AZT-induced tracheal smooth muscle contractile responses were also alteration in myocyte ultrastructure (Fig. 8) .
blunted in AZT-Rs in the course of the present study (Bova et al., unpublished data). It remains to be ascertained whether the reduced aortic contractile responsiveness in 4 . Discussion AZT-Rs is related to the reduced number of myocytes. An additional, endothelium-dependent mechanism could be In this study we investigated the effects induced by 240 implicated in the decreased contractile responses to days of AZT treatment on echocardiographic parameters, phenylephrine. It is well known that a-adrenergic receptors SBP, morphology of cardiac and vascular myocytes, and are also located on the endothelial cells, where they induce vascular contractile function in rats.
the release of the relaxing factor nitric oxide (NO) [19, 20] . Our results confirm that AZT induces ultrastructural Therefore, the a-adrenergic-induced contractile responses alterations of the rat cardiac mitochondria, which, however of endothelium-intact vascular preparations are the net do not strictly parallel in severity those reported following result of actions mediating two opposing effects in the shorter treatments. Indeed, we did not detect the disruption vascular smooth muscle, i.e., contraction and relaxation. of mitochondrial cristae described in previous investiga-
The finding that the phenylephrine-precontracted aortas of tions [5] [6] [7] . Although this discrepancy may be ascribed to AZT-Rs more strongly respond to the muscarinic agonist fixation-embedding artefacts in previous studies, partial carbachol with greater relaxation as compared to CNT-Rs, mitochondrial morphologic recovery during prolonged suggests an increased capability of the endothelium of treatment cannot be excluded. The ultrastructural finding AZT-Rs to produce NO. This could occur not only in of an increased number of mitochondria in cardiac response to muscarinic stimulation, but also to a-adrenmyocytes may explain why AZT-Rs did not show signs of ergic activation, thus contributing to the decreased contraccardiac contractile dysfunction on echocardiographic tile response to phenylephrine. This hypothesis can be 
